Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
Public ClinicalTrials.gov record NCT05636228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Patients With Acute Infectious Keratoconjunctivitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 2, randomized study to assess topically administered eyedrops of INV-102 compared to vehicle during 1-week dosing in participants with Acute Infectious Keratoconjunctivitis (AIK). Participants will return for a follow up visit 1 week after end of treatment.
Study identification
- NCT ID
- NCT05636228
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 93 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 9, 2023 (Actual)
- Primary completion
- Aug 22, 2024 (Actual)
- Completion
- Aug 22, 2024 (Actual)
- Last update posted
- Sep 18, 2026
2023 – 2024
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Global Research Management | Glendale | California | 91204 | — |
| Foothill Eye Institute | Pasadena | California | 91107 | — |
| Shettle Eye Research | Largo | Florida | 33773 | — |
| D & H National Research Centers, INC | Miami | Florida | 33155 | — |
| My Community Research Center, Inc. | Miami | Florida | 33155 | — |
| Quantum Clinical Trials | Miami Beach | Florida | 33140 | — |
| Kannarr Eye Center | Pittsburg | Kansas | 66762 | — |
| Oculos Clinical Research | Garner | North Carolina | 27529 | — |
| Athens Eye Care | Athens | Ohio | 45701 | — |
| Revolution Research/ Lake Travis Eye and Laser Center | Lakeway | Texas | 78738 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05636228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05636228 live on ClinicalTrials.gov.